-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Passage BIO, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q4 2024.
- Passage BIO, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$14.3M, a 22.6% increase year-over-year.
- Passage BIO, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$70.4M, a 35% increase year-over-year.
- Passage BIO, Inc. annual Operating Income (Loss) for 2024 was -$70.4M, a 35% increase from 2023.
- Passage BIO, Inc. annual Operating Income (Loss) for 2023 was -$108M, a 21.7% increase from 2022.
- Passage BIO, Inc. annual Operating Income (Loss) for 2022 was -$138M, a 25.5% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)